vs
德康医疗（DXCM）与StoneX Group Inc.（SNEX）财务数据对比。点击上方公司名可切换其他公司
德康医疗的季度营收约是StoneX Group Inc.的1.0倍（$1.3B vs $1.2B），德康医疗净利率更高（21.2% vs 11.6%，领先9.6%），StoneX Group Inc.同比增速更快（81.0% vs 21.6%），过去两年StoneX Group Inc.的营收复合增速更高（53.5% vs 12.0%）
德康医疗是美国跨国医疗保健企业，专注于研发、生产及销售糖尿病管理领域的连续血糖监测（CGM）系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥，生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
StoneX集团是美国知名金融服务企业，核心业务覆盖商业套期保值、全球支付、证券、实物大宗商品、外汇，以及清算与执行服务六大板块，可为全球各类客户提供专业合规的多元化金融服务。
DXCM vs SNEX — 直观对比
营收规模更大
DXCM
是对方的1.0倍
$1.2B
营收增速更快
SNEX
高出59.5%
21.6%
净利率更高
DXCM
高出9.6%
11.6%
两年增速更快
SNEX
近两年复合增速
12.0%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $1.2B |
| 净利润 | $267.3M | $139.0M |
| 毛利率 | 62.9% | — |
| 营业利润率 | 25.6% | 15.4% |
| 净利率 | 21.2% | 11.6% |
| 营收同比 | 21.6% | 81.0% |
| 净利润同比 | 153.6% | 63.3% |
| 每股收益（稀释后） | $0.67 | $2.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DXCMSNEX
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.2B | ||
| Q3 25 | $1.2B | $32.7B | ||
| Q2 25 | $1.2B | $851.2M | ||
| Q1 25 | $1.0B | $820.4M | ||
| Q4 24 | $1.1B | $663.1M | ||
| Q3 24 | $994.2M | $31.1B | ||
| Q2 24 | $1.0B | $571.8M |
净利润DXCMSNEX
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $139.0M | ||
| Q3 25 | $283.8M | $85.7M | ||
| Q2 25 | $179.8M | $63.4M | ||
| Q1 25 | $105.4M | $71.7M | ||
| Q4 24 | $151.7M | $85.1M | ||
| Q3 24 | $134.6M | $76.7M | ||
| Q2 24 | $143.5M | $61.9M |
毛利率DXCMSNEX
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | 3.7% | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | 3.0% | ||
| Q2 24 | 62.4% | — |
营业利润率DXCMSNEX
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 15.4% | ||
| Q3 25 | 20.1% | 0.3% | ||
| Q2 25 | 18.4% | -1.3% | ||
| Q1 25 | 12.9% | -1.0% | ||
| Q4 24 | 17.0% | -3.2% | ||
| Q3 24 | 15.3% | -0.0% | ||
| Q2 24 | 15.7% | -4.7% |
净利率DXCMSNEX
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 11.6% | ||
| Q3 25 | 23.5% | 0.3% | ||
| Q2 25 | 15.5% | 7.4% | ||
| Q1 25 | 10.2% | 8.7% | ||
| Q4 24 | 13.6% | 12.8% | ||
| Q3 24 | 13.5% | 0.2% | ||
| Q2 24 | 14.3% | 10.8% |
每股收益（稀释后）DXCMSNEX
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $2.50 | ||
| Q3 25 | $0.70 | $0.72 | ||
| Q2 25 | $0.45 | $1.22 | ||
| Q1 25 | $0.27 | $1.41 | ||
| Q4 24 | $0.37 | $1.69 | ||
| Q3 24 | $0.34 | $2.32 | ||
| Q2 24 | $0.35 | $1.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $917.7M | $1.6B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.7B | $2.5B |
| 总资产 | $6.3B | $47.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DXCMSNEX
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $1.6B | ||
| Q3 25 | $1.8B | $1.6B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $904.9M | $1.3B | ||
| Q4 24 | $606.1M | $1.4B | ||
| Q3 24 | $621.2M | $1.3B | ||
| Q2 24 | $939.2M | $1.2B |
股东权益DXCMSNEX
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $2.5B | ||
| Q3 25 | $2.7B | $2.4B | ||
| Q2 25 | $2.6B | $2.0B | ||
| Q1 25 | $2.3B | $1.9B | ||
| Q4 24 | $2.1B | $1.8B | ||
| Q3 24 | $2.0B | $1.7B | ||
| Q2 24 | $2.4B | $1.6B |
总资产DXCMSNEX
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $47.8B | ||
| Q3 25 | $7.5B | $45.3B | ||
| Q2 25 | $7.3B | $34.3B | ||
| Q1 25 | $6.8B | $31.3B | ||
| Q4 24 | $6.5B | $29.6B | ||
| Q3 24 | $6.4B | $27.5B | ||
| Q2 24 | $6.8B | $25.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-1.3B |
| 自由现金流经营现金流 - 资本支出 | — | $-1.3B |
| 自由现金流率自由现金流/营收 | — | -106.4% |
| 资本支出强度资本支出/营收 | — | 1.3% |
| 现金转化率经营现金流/净利润 | — | -9.08× |
| 过去12个月自由现金流最近4个季度 | — | $3.5B |
8季度趋势，按日历期对齐
经营现金流DXCMSNEX
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $-1.3B | ||
| Q3 25 | $659.9M | $3.5B | ||
| Q2 25 | $303.0M | $1.5B | ||
| Q1 25 | $183.8M | $-154.5M | ||
| Q4 24 | $301.4M | $-477.8M | ||
| Q3 24 | $199.5M | $192.6M | ||
| Q2 24 | $279.4M | $-622.1M |
自由现金流DXCMSNEX
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $-1.3B | ||
| Q3 25 | $579.4M | $3.5B | ||
| Q2 25 | $208.9M | $1.5B | ||
| Q1 25 | $96.8M | $-169.8M | ||
| Q4 24 | $176.8M | $-491.4M | ||
| Q3 24 | $88.3M | $175.9M | ||
| Q2 24 | $213.3M | $-640.5M |
自由现金流率DXCMSNEX
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | -106.4% | ||
| Q3 25 | 47.9% | 10.7% | ||
| Q2 25 | 18.1% | 173.3% | ||
| Q1 25 | 9.3% | -20.7% | ||
| Q4 24 | 15.9% | -74.1% | ||
| Q3 24 | 8.9% | 0.6% | ||
| Q2 24 | 21.2% | -112.0% |
资本支出强度DXCMSNEX
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 1.3% | ||
| Q3 25 | 6.7% | 0.1% | ||
| Q2 25 | 8.1% | 1.9% | ||
| Q1 25 | 8.4% | 1.9% | ||
| Q4 24 | 11.2% | 2.1% | ||
| Q3 24 | 11.2% | 0.1% | ||
| Q2 24 | 6.6% | 3.2% |
现金转化率DXCMSNEX
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | -9.08× | ||
| Q3 25 | 2.33× | 41.18× | ||
| Q2 25 | 1.69× | 23.52× | ||
| Q1 25 | 1.74× | -2.15× | ||
| Q4 24 | 1.99× | -5.61× | ||
| Q3 24 | 1.48× | 2.51× | ||
| Q2 24 | 1.95× | -10.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
